Real-world efficacy of anti-PD-1 antibodies in advanced acral melanoma patients: A retrospective, multicenter study (JAMP study).

被引：2
|
作者：
Nakamura, Yasuhiro
Namikawa, Kenjiro
Yoshino, Koji
Yoshikawa, Shusuke
Uchi, Hiroshi
Goto, Katsunobu
Nakamura, Yoshiyuki
Fukushima, Satoshi
Kiniwa, Yukiko
Takenouchi, Tatsuya
Uhara, Hisashi
Kawai, Toru
Hatta, Naohito
Funakoshi, Takeru
Teramoto, Yukiko
Otsuka, Atsushi
Doi, Haruki
Ogata, Dai
Matsushita, Shigeto
Yamazaki, Naoya
机构：
[1] Saitama Med Univ, Int Med Ctr, Saitama, Japan
[2] Natl Canc Ctr, Dept Dermatol Oncol, Tokyo, Japan
[3] Metropritan Komagome Hosp, Tokyo, Japan
[4] Shizuoka Canc Ctr, Dept Dermatol, Shizuoka, Japan
[5] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka, Fukuoka, Japan
[6] Nagoya Univ, Nagoya, Aichi, Japan
[7] Univ Tsukuba, Tsukuba, Ibaraki, Japan
[8] Kumamoto Univ, Grad Sch Med Sci, Fac Life Sci, Dept Dermatol & Plast Surg, Kumamoto, Japan
[9] Shinshu Univ, Matsumoto, Nagano, Japan
[10] Niigata Canc Ctr Hosp, Dept Dermatol, Niigata, Japan
[11] Sapporo Med Univ, Sch Med, Sapporo, Hokkaido, Japan
[12] Univ Tokyo, Tokyo, Japan
[13] Toyama Prefectural Hosp, Toyama, Japan
[14] Keio Univ, Tokyo, Japan
[15] Kyoto Univ, Kyoto, Japan
[16] Asahikawa Med Univ, Asahikawa, Hokkaido, Japan
[17] Saitama Med Univ, Dept Dermatol, Saitama, Japan
[18] Natl Hosp Org Kagoshima Med Ctr, Dept Dermatooncol Dermatol, Kagoshima, Japan
[19] Natl Canc Ctr, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.9529
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9529
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter study
    Umeda, Yoshiyasu
    Yoshikawa, Shusuke
    Kiniwa, Yukiko
    Maekawa, Takeo
    Yamasaki, Osamu
    Isei, Taiki
    Matsushita, Shigeto
    Nomura, Motoo
    Nakai, Yasuo
    Fukushima, Satoshi
    Saito, Shintaro
    Takenouchi, Tatsuya
    Tanaka, Ryo
    Kato, Hiroshi
    Otsuka, Atsushi
    Matsuya, Taisuke
    Baba, Natsuki
    Nagase, Kotaro
    Inozume, Takashi
    Onuma, Takehiro
    Kuwatsuka, Yutaka
    Fujimoto, Noriki
    Kaneko, Takahide
    Onishi, Masazumi
    Namikawa, Kenjiro
    Yamazaki, Naoya
    Nakamura, Yasuhiro
    [J]. EUROPEAN JOURNAL OF CANCER, 2021, 157 : 361 - 372
  • [2] Efficacy of salvage therapies for advanced acral melanoma after anti-PD-1 monotherapy failure: a multicenter retrospective study of 108 Japanese patients
    Mori, Tatsuhiko
    Namikawa, Kenjiro
    Yamazaki, Naoya
    Kiniwa, Yukiko
    Yamasaki, Osamu
    Yoshikawa, Shusuke
    Inozume, Takashi
    Kato, Hiroshi
    Nakai, Yasuo
    Fukushima, Satoshi
    Takenouchi, Tatsuya
    Maekawa, Takeo
    Matsushita, Shigeto
    Otsuka, Atsushi
    Nomura, Motoo
    Baba, Natsuki
    Isei, Taiki
    Saito, Shintaro
    Fujimoto, Noriki
    Tanaka, Ryo
    Kaneko, Takahide
    Kuwatsuka, Yutaka
    Matsuya, Taisuke
    Nagase, Kotaro
    Onishi, Masazumi
    Onuma, Takehiro
    Nakamura, Yasuhiro
    [J]. FRONTIERS IN MEDICINE, 2023, 10
  • [3] A real-world study of the efficacy and safety of anti-PD-1 antibodies plus lenvatinib in patients with advanced gallbladder cancer
    Bangyou Zuo
    Xiaobo Yang
    Xu Yang
    Jin Bian
    Junyu Long
    Dongxu Wang
    Cong Ning
    Yanyu Wang
    Ziyu Xun
    Yunchao Wang
    Xin Lu
    Yilei Mao
    Xinting Sang
    Haitao Zhao
    [J]. Cancer Immunology, Immunotherapy, 2022, 71 : 1889 - 1896
  • [4] A real-world study of the efficacy and safety of anti-PD-1 antibodies plus lenvatinib in patients with advanced gallbladder cancer
    Zuo, Bangyou
    Yang, Xiaobo
    Yang, Xu
    Bian, Jin
    Long, Junyu
    Wang, Dongxu
    Ning, Cong
    Wang, Yanyu
    Xun, Ziyu
    Wang, Yunchao
    Lu, Xin
    Mao, Yilei
    Sang, Xinting
    Zhao, Haitao
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (08) : 1889 - 1896
  • [5] Real-world outcomes of combined lenvatinib and anti-PD-1 in advanced melanoma: Lenvamel, a multicenter retrospective study of the French Group of Skin Cancers
    Rousset, Perrine
    Nardin, Charlee
    Maubec, Eve
    Heidelberger, Valentine
    Picard, Alexandra
    Gerard, Emilie
    Kramkimel, Nora
    Steff, Maud
    Quereux, Gaelle
    Gaudy-Marqueste, Caroline
    Lesage, Candice
    Mignard, Claire
    Jeudy, Geraldine
    Jouary, Thomas
    Saint-Jean, Melanie
    Baroudjian, Barouyr
    Archier, Elodie
    Mortier, Laurent
    Lebbe, Celeste
    Montaudie, Henri
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Comparing the clinical efficacies of anti-PD-1 antibody monotherapy and anti-PD-1 and anti-CTLA-4 combination therapy as first-line immunotherapy in Japanese advanced acral melanoma: A retrospective, multicenter study (JAMP-neo study).
    Nakamura, Yasuhiro
    Kiniwa, Yukiko
    Kato, Hiroshi
    Yamasaki, Osamu
    Maekawa, Takeo
    Matsushita, Shigeto
    Takenouchi, Tatsuya
    Inozume, Takashi
    Nakai, Yasuo
    Fukushima, Satoshi
    Saito, Shintaro
    Otsuka, Atsushi
    Fujimoto, Noriki
    Isei, Taiki
    Baba, Natsuki
    Matsuya, Taisuke
    Tanaka, Ryo
    Kaneko, Takahide
    Onishi, Masazumi
    Yoshikawa, Shusuke
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Efficacy and safety of anti-PD-1 monotherapy versus anti-PD-1 antibodies plus lenvatinib in patients with advanced hepatocellular carcinoma: a real-world experience
    Liu, Qingyan
    Li, Rong
    Li, Lingling
    Wang, Gaokun
    Ji, Shiyu
    Zheng, Xuan
    Jia, Xiaodong
    Tao, Haitao
    Hu, Yi
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [8] Efficacy and safety of anti-PD-1 agents in patients with dMMR metastatic solid tumours: A retrospective, real-world study
    Teran Brage, E.
    Vidal Tocino, R.
    Moreno Gomez, A.
    Figuero Perez, L.
    Lopez Gutierrez, A.
    Lozano Mejorada, R.
    Fonseca Sanchez, E.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S325 - S325
  • [9] Adjuvant treatment with anti-PD-1 in acral melanoma patients: A nationwide study
    Bloem, M.
    van Not, O. J.
    Haanen, J. B. A. G.
    Blank, C. U.
    Aarts, M. J. B.
    Van den Berkmortel, F. W. P. J.
    de Groot, J. W.
    Hospers, G. A. P.
    Kapiteijn, E.
    Piersma, D.
    van Rijn, R. S.
    Boer, M. Stevense-den
    Van der Veldt, A. A. M.
    Vreugdenhil, G.
    Bonenkamp, H.
    Boers-Sonderen, M. J.
    Blokx, W. A.
    Van Den Eertwegh, F.
    Suijkerbuijk, K. P. M.
    Wouters, M.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S658 - S658
  • [10] Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patients
    Nakamura, Yasuhiro
    Namikawa, Kenjiro
    Kiniwa, Yukiko
    Kato, Hiroshi
    Yamasaki, Osamu
    Yoshikawa, Shusuke
    Maekawa, Takeo
    Matsushita, Shigeto
    Takenouchi, Tatsuya
    Inozume, Takashi
    Nakai, Yasuo
    Fukushima, Satoshi
    Saito, Shintaro
    Otsuka, Atsushi
    Fujimoto, Noriki
    Isei, Taiki
    Baba, Natsuki
    Matsuya, Taisuke
    Tanaka, Ryo
    Kaneko, Takahide
    Onishi, Masazumi
    Kuwatsuka, Yutaka
    Nagase, Kotaro
    Onuma, Takehiro
    Nomura, Motoo
    Umeda, Yoshiyasu
    Yamazaki, Naoya
    [J]. EUROPEAN JOURNAL OF CANCER, 2022, 176 : 78 - 87
12345